Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Dongmei Gao, Guihua Dong, Lijun Zhu, Nina Jia & Baijun Sun. (2023) Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021. Human Vaccines & Immunotherapeutics 19:2.
Read now
Read now
Fuxing Chen, Xuejiao Pan, Hui Liang, Lingzhi Shen, Ying Wang, Yaping Chen, Huakun Lv & Yu Hu. (2022) Real-world safety profile of the 9-valent human papillomavirus vaccine: A study in Zhejiang, China from 2019 to 2021. Human Vaccines & Immunotherapeutics 18:7.
Read now
Read now
Huakun Lv, Xuejiao Pan, Ying Wang, Hui Liang & Hu Yu. (2022) Barriers to healthcare workers reporting adverse events following immunization in Zhejiang province, China. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Laurence Serradell, Sophie Wagué, Annick Moureau, Markku Nissilä & Anne-Laure Chabanon. (2021) Enhanced passive safety surveillance of a trivalent and a quadrivalent influenza vaccine in Denmark and Finland during the 2018/2019 season. Human Vaccines & Immunotherapeutics 17:4, pages 1205-1210.
Read now
Read now
Pasquale Stefanizzi, Sara De Nitto, Francesco Patano, Francesco Paolo Bianchi, Davide Ferorelli, Paolo Stella, Domenica Ancona, Vito Bavaro & Silvio Tafuri. (2020) Post-marketing surveillance of adverse events following measles, mumps, rubella and varicella (MMRV) vaccine: retrospecive study in apulia region (ITALY), 2009-2017. Human Vaccines & Immunotherapeutics 16:8, pages 1875-1883.
Read now
Read now
Sonja Gandhi-Banga, Anne-Laure Chabanon, Cecile Eymin, Timothy Caroe, Karina Butler & Annick Moureau. (2019) Enhanced passive safety surveillance of three marketed influenza vaccines in the UK and the Republic of Ireland during the 2017/18 season. Human Vaccines & Immunotherapeutics 15:9, pages 2154-2158.
Read now
Read now
Anne Laure Chabanon, Hélène Bricout, Céline Ballandras, Audrey Souverain, Timothy David Caroe & Karina M. Butler. (2018) Report from enhanced safety surveillance of two influenza vaccines (Vaxigrip and Intanza 15 μg) in two European countries during influenza season 2016/17 and comparison with 2015/16 season. Human Vaccines & Immunotherapeutics 14:2, pages 378-385.
Read now
Read now
Silvio Tafuri, Maria Serena Gallone, Giulia Calabrese & Cinzia Germinario. (2015) Adverse events following immunization: is this time for the use of WHO causality assessment?. Expert Review of Vaccines 14:5, pages 625-627.
Read now
Read now
Articles from other publishers (13)
Sonja Gandhi‐Banga, Sophie Wague, Anju Shrestha, Olga Syrkina, Oxana Talanova, Markku Nissilä, Karl Stuff & Céline Monfredo. (2022) Enhanced passive safety surveillance of high‐dose and standard‐dose quadrivalent inactivated split‐virion influenza vaccines in Germany and Finland during the influenza season 2021/22. Influenza and Other Respiratory Viruses 17:1.
Crossref
Crossref
Olga Syrkina, Ajinkya Inamdar, Sophie Wague, Céline Monfredo, Markku Nissilä, Anne-Laure Chabanon & Laurence Serradell. (2022) Enhanced passive safety surveillance of a quadrivalent inactivated split virion influenza vaccine in Finland during the influenza season 2020/21. BMC Public Health 22:1.
Crossref
Crossref
Anne-Laure Chabanon, Sophie Wague, Annick Moureau, Markku Nissila & Laurence Serradell. (2021) Enhanced passive safety surveillance of the quadrivalent inactivated split-virion influenza vaccine (IIV4) in Finland during the 2019/20 influenza season. BMC Public Health 21:1.
Crossref
Crossref
Jun Gao, Guodong Kang, Ran Hu, Lei Zhang, Jing Yu, Zhiguo Wang & Fenyang Tang. (2021) Adverse events following immunization with bivalent oral poliovirus vaccine in Jiangsu, China. British Journal of Clinical Pharmacology 87:12, pages 4831-4838.
Crossref
Crossref
Roshan Anna Thomas, Marina Rajan Joseph, Anne–Marie Castilloux & Yola Moride. (2021) Understanding reporting practices and perceptions of barriers in adverse events following immunisation surveillance: A cross–sectional survey of paediatricians in Kerala, India. Vaccine 39:33, pages 4678-4684.
Crossref
Crossref
F. Moretti, L. Gonella, S. Gironi, A. R. Marra, C. Santuccio, P. Felicetti, F. Petronzelli, P. Marchione, S. A. Barnaba, A. Poli, G. Zanoni & U. Moretti. (2020) Ten years of vaccinovigilance in Italy: an overview of the pharmacovigilance data from 2008 to 2017. Scientific Reports 10:1.
Crossref
Crossref
Jorgen Bauwens, Luis-Henri Saenz, Annina Reusser, Nino Künzli & Jan Bonhoeffer. (2019) Safety of Co-Administration Versus Separate Administration of the Same Vaccines in Children: A Systematic Literature Review. Vaccines 8:1, pages 12.
Crossref
Crossref
Robert T. Chen, Jason M. Glanz & Tom T. Shimabukuro. 2019. Pharmacoepidemiology. Pharmacoepidemiology
437
495
.
Meredith Woodward, Ann Marko, Susan Galea, Barry Eagel & Walter Straus. (2019) Varicella Virus Vaccine Live: A 22-Year Review of Postmarketing Safety Data. Open Forum Infectious Diseases 6:8.
Crossref
Crossref
Guido Castelli Gattinara, Elena Bellelli, Donatella F. Angelone, Veronica Santilli & Luciana Nicolosi. 2017. Vaccines. Vaccines.
Luis Felipe Ensina, Mara Morelo Rocha Félix & Carolina Sanchez Aranda. (2016) Drug-Induced Anaphylaxis: Clinical Scope, Management, and Prevention. Current Treatment Options in Allergy 3:3, pages 243-252.
Crossref
Crossref
Michael P. Sherman, Curtis J. Pritzl, Chuan Xia, Mindy M. Miller, Habib Zaghouani & Bumsuk Hahm. (2015) Lactoferrin acts as an adjuvant during influenza vaccination of neonatal mice. Biochemical and Biophysical Research Communications 467:4, pages 766-770.
Crossref
Crossref
Bradford S. Powell, Alexander K. Andrianov & Peter C. Fusco. (2015) Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes. Clinical and Experimental Vaccine Research 4:1, pages 23.
Crossref
Crossref